EdgeTestMarket TodayOptions TodayIPO
Start free

SICAGENSicagen India Limited

Rs 48.17▼ -0.56%
Market closedEquity EOD 26 Oct
Compare
Range since listingThe lowest and highest prices the stock traded at over the last year, from each day's intraday low and high. The marker is today's close: 0% means it sits at the year's low, 100% at the high. It describes where the price is, not where it is going.5.9% up the range
Rs 47Rs 74
SICAGEN price
Daily candles, adjusted for splits and bonus issues so a corporate action does not show as a crash. Pick a window from one month to the full history, add indicators, or open it full screen.
EOD 26 Oct
IndicatorsVolume

Loading SICAGEN price...

What the numbers say
Short lines written by fixed rules from the company's own filings and shareholding. A line appears only when the figures cross the rule (for example sales growing three years running), and each names the numbers behind it. Nothing here is a view on whether to own the share.

Latest quarterIn the quarter to March 2021 (results filed 27 May 2021), sales was Rs 200 cr and profit was Rs 3.8 cr.

Nothing in the filings we hold crosses one of our rules yet. Each rule needs a few complete years of results, so recently listed companies often show nothing here.

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

Fundamentals
Trailing-twelve-month valuation, margins and growth from the company's own filings.

We do not have quarterly financials for SICAGEN yet. Some companies, mainly insurers, file in a format we cannot read at the moment. Everything else on this page is current.

Dividends paid
Cash paid per share, from the exchange's corporate-action record, restated to today's share count across bonuses and splits. Dates shown are ex-dates: you must own the shares before that date to receive the payment.
Rs 1,038 in 2020
Paid 3 of 5 yrs
what 2020's payouts come to on Rs 1 lakh at today's price · nothing declared in the last twelve months
What each year paid, on Rs 1 lakh
1,246
830
1,038
16
17
18
19
20

2020 paid Rs 0.50 per share, about Rs 1,038 on Rs 1 lakh at today's price. It skipped 2 of the last 5 years. Dividends are at the company's discretion and can be cut or skipped.

Large institutional deals
Bulk and block deals reported by the exchange, where a single large trade is disclosed along with the counterparty's name. Only deals above the exchange's disclosure threshold appear here.
last 2
DatePartySideQtyPriceValue
2026-08-07ANKITA VISHAL SHAHBUY2,98,52573.43Rs 2.19 Cr
2026-08-07ANKITA VISHAL SHAHSELL1,17,04674.06Rs 0.87 Cr
Technical snapshot
Momentum, trend and delivery-based conviction from the actual price and volume history.
EOD 26 Oct
RSI (14) - momentum
34.3Neutral
0 oversold3070overbought 100
Delivery % - genuine buying vs churn
72%Near average
today 72%20d avg 79.8%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50-DMA
-10.00%
vs 200-DMA
-
1-month
-9.08%
3-month
-4.86%
1-year
-
Realized vol (30d)
26.8%
Insider trading disclosures
Promoter, director and other insider trades in the company's own shares, as disclosed to the exchange under SEBI's insider-trading regulations - usually within a few days of the transaction.
last 18 months

Insider trading data unavailable.

Recent announcements
The company's own filings to the exchange - results, board meetings, investor calls - with a link to the source document.
last 6 months

Announcements unavailable.

Want to test a strategy on SICAGEN?

Backtest an equity strategy on real market data, free - no card needed.

Start free

Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.